Femasys (FEMY) Revenue Growth (1y) (2021 - 2025)
Femasys (FEMY) Revenue Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.74 Bn | 121.53 Bn | 1.96 Bn | 18.54% |
| 2 | Becton Dickinson | 44.95 Bn | 44.14 Bn | 2.15 Bn | 5.22% |
| 3 | Alcon | 33.20 Bn | 31.54 Bn | 1.53 Bn | - |
| 4 | Medline | 32.84 Bn | 30.60 Bn | 1.84 Bn | 10.66% |
| 5 | Resmed | 29.49 Bn | 27.83 Bn | 890.98 Mn | 10.81% |
| 6 | West Pharmaceutical Services | 23.32 Bn | 22.89 Bn | 329.20 Mn | 13.80% |
| 7 | Solventum | 14.08 Bn | 13.51 Bn | 1.10 Bn | -3.04% |
| 8 | Cooper Companies | 13.86 Bn | 13.72 Bn | 735.40 Mn | 7.90% |
| 9 | Align Technology | 12.11 Bn | 11.05 Bn | 736.59 Mn | 6.21% |
| 10 | Femasys | 14.28 Mn | 8.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 84.78% |
| Mar 31, 2025 | 25.86% |
| Dec 31, 2024 | 172.90% |
| Sep 30, 2024 | 127.09% |
| Jun 30, 2024 | -30.90% |
| Mar 31, 2024 | -7.77% |
| Dec 31, 2023 | -9.02% |
| Sep 30, 2023 | -29.67% |
| Jun 30, 2023 | 5.74% |
| Mar 31, 2023 | -8.53% |
| Dec 31, 2022 | -7.90% |
| Sep 30, 2022 | 28.89% |
| Jun 30, 2022 | -7.02% |
| Mar 31, 2022 | -2.54% |
| Dec 31, 2021 | -9.48% |
| Sep 30, 2021 | -13.93% |
| Jun 30, 2021 | 77.92% |